Protective Effects of Grapeseed Proanthocyanidins in Ulcerative Colitis: A Pilot Study Evaluating a Potential Therapeutic Strategy

<b>Background/Objectives</b>: Recent research highlights <i>Vitis vinifera</i> seeds as a rich source of bioactive proanthocyanidins (PACs) with antioxidant and immunomodulatory effects. Poorly absorbed PACs are metabolized by gut microbiota into active phenolic metabolites. This pilot study in ulcerative colitis patients assessed grape seed extract effects on microbiota, zonulin-related permeability, and quality of life. <b>Methods</b>: This prospective pilot study, conducted at the University Hospital of Padua, evaluated the effects of an eight-week treatment with proanthocyanidins (ECOVITIS<sup>®</sup>) on gut microbiota, intestinal permeability (zonulin), and well-being in patients with ulcerative colitis in remission (IBDQ). Fecal and serum samples were collected at T0 and T1. Microbiota analysis was performed through 16S rRNA gene sequencing (QIIME2), zonulin was quantified using an ELISA kit for pre-haptoglobin gene2 (pre-HP2), and HP1/HP2 genotyping was conducted by quantitative PCR. Statistical analyses (Wilcoxon, ALDEx2, PERMANOVA) assessed microbial diversity and taxonomic changes between pre- and post-treatment samples. <b>Results</b>: Twenty-five ulcerative colitis patients completed the study. IBDQ scores significantly improved after treatment (mean Δ = +11.2, <i>p</i> < 0.001), especially in the 11 best IBDQ responders (Δ = +24.2, <i>p</i> < 0.001). Microbiota analysis showed increased <i>Lachnospiraceae</i> and <i>Sutterellaceae</i> in responders, while overall diversity remained unchanged. Zonulin levels were unaffected. <b>Conclusions:</b> PAC treatment improved quality of life in ulcerative colitis patients, as shown by increased IBDQ scores. Serum zonulin levels remained unchanged. Microbiota analysis revealed enrichment of <i>Lachnospiraceae</i> and <i>Sutterellaceae</i> families, suggesting beneficial modulation. Limitations include lack of metabolic assessment and a control group, and caution is needed in interpreting zonulin measurements.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-01-21
DOI
https://doi.org/10.3390/jcm15020888
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protective Effects of Grapeseed Proanthocyanidins in Ulcerative Colitis: A Pilot Study Evaluating a Potential Therapeutic Strategy

Elena Agostini, Edoardo Vincenzo Savarino, Luisa Bertin, Sonia Facchin et al.
Journal of Clinical Medicine
Gut microbiota and health
article

Protective Effects of Grapeseed Proanthocyanidins in Ulcerative Colitis: A Pilot Study Evaluating a Potential Therapeutic Strategy

Elena Agostini, Edoardo Vincenzo Savarino, Luisa Bertin, Sonia Facchin, Giuseppe Benvenuto, Giorgio Valle, Elisa Laparra-Ruiz
article en

Abstract

<b>Background/Objectives</b>: Recent research highlights <i>Vitis vinifera</i> seeds as a rich source of bioactive proanthocyanidins (PACs) with antioxidant and immunomodulatory effects. Poorly absorbed PACs are metabolized by gut microbiota into active phenolic metabolites. This pilot study in ulcerative colitis patients assessed grape seed extract effects on microbiota, zonulin-related permeability, and quality of life. <b>Methods</b>: This prospective pilot study, conducted at the University Hospital of Padua, evaluated the effects of an eight-week treatment with proanthocyanidins (ECOVITIS<sup>®</sup>) on gut microbiota, intestinal permeability (zonulin), and well-being in patients with ulcerative colitis in remission (IBDQ). Fecal and serum samples were collected at T0 and T1. Microbiota analysis was performed through 16S rRNA gene sequencing (QIIME2), zonulin was quantified using an ELISA kit for pre-haptoglobin gene2 (pre-HP2), and HP1/HP2 genotyping was conducted by quantitative PCR. Statistical analyses (Wilcoxon, ALDEx2, PERMANOVA) assessed microbial diversity and taxonomic changes between pre- and post-treatment samples. <b>Results</b>: Twenty-five ulcerative colitis patients completed the study. IBDQ scores significantly improved after treatment (mean Δ = +11.2, <i>p</i> < 0.001), especially in the 11 best IBDQ responders (Δ = +24.2, <i>p</i> < 0.001). Microbiota analysis showed increased <i>Lachnospiraceae</i> and <i>Sutterellaceae</i> in responders, while overall diversity remained unchanged. Zonulin levels were unaffected. <b>Conclusions:</b> PAC treatment improved quality of life in ulcerative colitis patients, as shown by increased IBDQ scores. Serum zonulin levels remained unchanged. Microbiota analysis revealed enrichment of <i>Lachnospiraceae</i> and <i>Sutterellaceae</i> families, suggesting beneficial modulation. Limitations include lack of metabolic assessment and a control group, and caution is needed in interpreting zonulin measurements.

Journal of Clinical MedicineVol. 15(2)
University of Padua (IT), Biomolecular Research Genomics (Italy) (IT), Azienda Ospedale - Università Padova (IT)
Pfizer, Sanofi, Regeneron Pharmaceuticals
Openalex Percentile: Top 77%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.